Stock VNDA VANDA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Real-time Estimate Cboe BZX
Other stock markets
 12:46:29 2024-04-25 pm EDT 		5-day change 1st Jan Change
4.455 USD -2.30% Intraday chart for Vanda Pharmaceuticals Inc. -10.06% +5.92%
03:00pm Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer RE
Apr. 22 Vanda Pharmaceuticals Appeal for Patents on Sleep Drug Declined by US Supreme Court MT

Chart calendar Vanda Pharmaceuticals Inc.

f831ae56fa60990489583c352c3.2jDfZRe_D2aKUuwl3waRDYQkeIj9l13XLAJXS93UqQM.nQaYLHD5dyf8KIVkrnekaOdOAM-p9DrmYGMzAbK403v3UrMyRvtJELhitQ~2ffe898de3074d8bfe2a5ad277151dbd

Upcoming events on Vanda Pharmaceuticals Inc.

2024-04-30 Q1 2024 Earnings Release (Projected)
2024-07-30 Q2 2024 Earnings Release (Projected)
2024-10-29 Q3 2024 Earnings Release (Projected)
2025-02-04 Q4 2024 Earnings Release (Projected)

Past events on Vanda Pharmaceuticals Inc.

2024-02-07 04:30 pm Q4 2023 Earnings Call
2024-02-07 04:02 pm Q4 2023 Earnings Release
2024-01-09 12:45 pm JPMorgan Healthcare Conference
2023-11-16 09:00 am Jefferies London Healthcare Conference
2023-11-14 04:10 pm Stifel Healthcare Conference
2023-11-08 04:30 pm Q3 2023 Earnings Call
2023-11-08 04:01 pm Q3 2023 Earnings Release
2023-10-11 01:25 pm Jefferies Inaugural Biotech CNS/Neuro Summit
2023-09-13 04:00 pm H.C. Wainwright Global Investment Conference
2023-07-27 04:30 pm Q2 2023 Earnings Call
2023-07-26 Q2 2023 Earnings Release After hours
2023-06-09 12:15 pm Jefferies Global Healthcare Conference
2023-06-08 09:00 am Annual General Meeting
2023-05-03 04:30 pm Q1 2023 Earnings Call
2023-05-03 04:01 pm Q1 2023 Earnings Release
2023-02-08 04:30 pm FY 2022 Earnings Call
2023-02-08 04:01 pm FY 2022 Earnings Release
2023-01-12 03:00 pm JP Morgan Healthcare Conference
2022-11-17 07:20 am Jefferies London Healthcare Conference
2022-11-15 10:20 am Stifel Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023
Net sales
Million USD		Released
Forecast
Spread 		227
226
0.61%		248
245
1.5%		269
271
-0.75%		254
258
-1.21%		193
184
4.47%
EBITDA
Million USD		Released
Forecast
Spread 		39,2
27,8
40.86%		0,00
0,00
- 		45,0
45,5
-1.04%		0,00
0,00
- 		0,00
0,00
-
EBIT
Million USD		Released
Forecast
Spread 		22,8
32,3
-29.38%		27,2
24,2
12.56%		42,2
40,4
4.45%		6,33
5,50
15.07%		-14,0
-18,4
24.17%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		29,0
33,9
-14.37%		31,7
25,9
22.22%		42,4
40,3
5.12%		11,3
6,20
82.26%		6,34
2,60
143.81%
Net income
Million USD		Released
Forecast
Spread 		116
121
-4.74%		23,3
24,1
-3.17%		33,2
31,1
6.58%		6,28
2,70
132.41%		2,51
-0,50
601.8%
EPS
USD		Released
Forecast
Spread 		2,11
2,17
-2.76%		0,42
0,46
-7.74%		0,58
0,54
8.41%		0,11
0,04
175%		0,04
-0,01
500%
Announcement Date25/02/2010/02/2123/02/2208/02/2307/02/24

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD		Released
Forecast
Spread 		68,0
70,0
-2.88%		60,2
58,0
3.78%		64,4
67,0
-3.9%		65,3
71,0
-8%		64,5
67,6
-4.61%		46,1
49,0
-6.01%		38,8
44,5
-12.78%		45,3
37,0
22.35%
EBITDA
Million USD		Released
Forecast
Spread 		9,34
9,28
0.72%




















EBIT
Million USD		Released
Forecast
Spread 		8,64
6,65
29.8%		-7,67
-0,60
-1178.17%		3,46
9,70
-64.32%		3,91
6,60
-40.79%		6,63
5,80
14.29%		-2,87
-9,40
69.5%		-6,00
-2,60
-130.58%		-7,09
-11,5
38.31%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		8,61
6,20
38.87%		-7,56
-0,60
-1160.67%		3,79
9,70
-60.93%		5,46
6,90
-20.86%		9,61
6,10
57.59%		2,59
-9,40
127.57%		-0,12
-2,60
95.38%		-1,66
-5,40
69.24%
Net income
Million USD		Released
Forecast
Spread 		7,08
4,87
45.42%		-6,43
-0,50
-1186%		2,57
7,70
-66.57%		3,27
5,40
-39.44%		6,86
4,80
42.94%		1,52
-7,50
120.27%		0,14
-2,60
105.27%		-2,40
-5,40
55.56%
EPS
USD		Released
Forecast
Spread 		0,12
0,09
41.18%		-0,11
-0,01
-1000%		0,05
0,12
-58.33%		0,06
0,09
-33.33%		0,12
0,08
50%		0,03
-0,13
123.08%		0,00
-0,04
- 		-0,04
-0,09
55.56%
Announcement Date23/02/2205/05/2203/08/2202/11/2208/02/2327/07/2308/11/2307/02/24

Upcoming sector events for Vanda Pharmaceuticals Inc.

2024-04-25 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-04-25 REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-28 HITGEN INC.: Q1 2024 Earnings Release (Projected)
2024-04-28 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Vanda Pharmaceuticals Inc.

Today 06:30 am SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
Today JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
Today BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)
Today PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
Today HITGEN INC.: Q4 2023 Earnings Release
2024-04-24 04:05 pm VIKING THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-23 INVENTISBIO CO., LIMITED: Q1 2024 Earnings Release (Projected)
2024-04-23 SINOCELLTECH GROUP LIMITED: Q1 2024 Earnings Release (Projected)
2024-04-23 SHANGHAI MEDICILON INC.: Q4 2023 Earnings Release
2024-04-23 07:30 am KINIKSA PHARMACEUTICALS, LTD.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. VNDA Stock
  4. Calendar Vanda Pharmaceuticals Inc.